SoftSol India Limited (BOM:532344)
India · Delayed Price · Currency is INR 250.95
-3.95 (-1.55%)
At close: Jul 31, 2025
Verve Therapeutics Revenue
In the fiscal year ending March 31, 2025, SoftSol India had annual revenue of 127.42M INR, down -5.71%. SoftSol India had revenue of 32.35M in the quarter ending March 31, 2025, a decrease of -108.06%.
Revenue
127.42M
Revenue Growth
-5.71%
P/S Ratio
28.83
Revenue / Employee
860.93K
Employees
148
Market Cap
3.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 127.42M | -7.71M | -5.71% |
| Mar 31, 2024 | 135.13M | -690.81M | -83.64% |
| Mar 31, 2023 | 825.94M | 83.30M | 11.22% |
| Mar 31, 2022 | 742.64M | 345.04M | 86.78% |
| Mar 31, 2021 | 397.60M | -47.95M | -10.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 638.72B |